Gynecologic Oncology
RSSArticles
-
Calcium supplements may not aid breast cancer
Calcium and vitamin D supplements are widely prescribed to women undergoing treatment for breast cancer to prevent and manage osteoporosis. Why? -
Clinicians continue unneeded pelvic exams
Results of a new national survey of obstetricians and gynecologists (OB/GYNs) show that many physicians mistakenly believe a routine annual bimanual pelvic examination is important in screening for ovarian cancer. -
STI Quarterly: Initiative launched to raise condom awareness
-
Washington Watch: Abortion coverage alters for servicewomen
In one of its final acts, the lame-duck 112th Congress did something unprecedented over its two-year term: It expanded access to publicly financed abortion, ever so slightly. -
STI Quarterly: STI snapshot: Chlamydia leads in national rates — Young most at risk
According to a just-released analysis of the latest national sexually transmitted infection (STI) surveillance data, 1.4 million new cases of chlamydia were reported in the United States in 2011. -
STI Quarterly: FDA approves new test for chlamydia/gonorrhea
The Food and Drug Administration (FDA) has given clearance to Cepheid of Sunnyvale, CA, to market its Xpert CT/NG test. -
STI Quarterly: Initiative launched to raise condom awareness
-
Sterilization option now under research
Sterilization continues to be a leading contraceptive choice for women in the United States; between 2006 and 2008, 10.3 million women looked to the method for birth control. -
FDA approves smaller levonorgestrel intrauterine system — a 'mini Mirena'
The Food and Drug Administration has given approval to Skyla, a new intrauterine system (IUS) from Bayer HealthCare Pharmaceuticals of Wayne, NJ. Available by prescription in February 2013, Skyla is the first new intrauterine contraceptive to receive U.S. approval in more than a decade. -
CT Updates: Make plans now to attend ACOG annual meeting